Use of these drugs has skyrocketed in recent years, including a more than 700% increase in GLP-1 use for weight management between 2019 and 2023
Pros Offers members access to GLP-1 medication and generic alternatives
If Weight-Management Drugs Are Covered The patient must meet prior authorization criteria , typically including: BMI documentation comorbidities weight history If Weight-Management Drugs Are Excluded The claim will typically be denied automatically
Long term, Gribble said, the US is a priority but its important for us to ensure that we work to bring our medicines beyond the US. Patent pending While Novos international patent has expired in several countries, it gets to hold on to its US-based semaglutide patent until 2032
those are not FDA-approved finished drug products, so if your stipend plan language requires FDA-approved medication, you'll want to confirm with your benefits administrator before submitting a claim
Be Strategic with Sleep and Scheduling Listen to your body when it tells you it needs rest
